Ang (1–7), a heptapeptide converted from Ang I by ACE and from Ang II by ACE2, binds to Mas (MAS, coded by MAS1) and inhibits proliferation of prostate cancer lines (Krishnan et al., 2013). Here, ACE is linked to prostate carcinoma.